Volume 11, Issue 3 (May-Jun 2017)                   mljgoums 2017, 11(3): 1-5 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Ghadami M, Shokoohizadeh L, Mirzaee M. Prevalence of Plasmid-Mediated Quinolones Resistance among Klebsiella pneumoniae Strains Isolated from Hospitals in Borujerd, Iran. mljgoums. 2017; 11 (3) :1-5
URL: http://mlj.goums.ac.ir/article-1-982-en.html
1- Department of laboratory Sciences, Borujerd Branch, Islamic Azad University, Borujrd, Iran
2- Department of Medical laboratory Sciences, School of Para medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran , shokoohizadeh-L@ajums.ac.ir
Abstract:   (10607 Views)
       Background and Objective: Klebsiella pneumoniae is one of the most common causes of bacterial infections. Presence of plasmid-mediated quinolone resistance genes causes low level of resistance in K. pneumoniae. This study investigated the prevalence of resistance to quinolones and fluoroquinolones, and the frequency of qnrA, qnrB and qnrS genes among K. pneumoniae strains.
        Methods: The study was performed on 100 K. pneumoniae strains isolated from hospitals in city of Borujerd (Iran) during April to September 2014. Susceptibility of the isolates to nalidixic acid, ciprofloxacin, norfloxacin and ofloxacin was evaluated. Minimum inhibitory concentration (MIC) of ciprofloxacin was determined using ciprofloxacin Etest strips. Polymerase chain reaction was performed to detect qnrA, qnrB and qnrS genes in quinolone-resistant isolates using specific primers.
      Results: The results showed that 38% of the isolates were resistance to both nalidixic acid and ciprofloxacin. The prevalence of ofloxacin- and norfloxacin-resistant isolates was determined to be 18% and 15%, respectively. The MIC values for ciprofloxacin were ranging from 0.064 to ≥256 μg/ml. In addition, four ciprofloxacin-resistant isolates (10%) had MIC of ≥256 μg/ml. The qnrA gene was not detected in any of the quinolone-resistant isolates. Moreover, 23.6% (n=9) and 5.2% (n=2) of the quinolones-resistant isolates contained the qnrB and qnrS genes, respectively.
      Conclusion: Although 38 isolates were ciprofloxacin-resistant, the qnrB, qnrS genes were detected in a small number of isolates. This indicates the involvement of factors other than the qnr genes in resistance of these isolates to quinolones.
       Keywords: Klebsiella Pneumoniae, Qnr protein, Borujerd.
Full-Text [PDF 654 kb]   (1007 Downloads)    
Research Article: Original Paper |
Received: 2017/08/8 | Accepted: 2017/08/8 | Published: 2017/08/8 | ePublished: 2017/08/8

1. Rashid T, Ebringer A. Ankylosing spondylitis is linked to Klebsiella-the evidence. Clinical Rheumatology. 2007; 26(3): 858-864. DOI: 10.1007/s10067-006-0488-7. [DOI:10.1007/s10067-006-0488-7]
2. Hudson C, Bent Zachary, Meagher, R, Williams K. Resistance Determinants and Mobile Genetic Elements of an NDM-1-Encoding Klebsiella pneumoniae strain". PLOS ONE 2014: 9: e99209. doi: 10.1371/journal.pone.0099209. [DOI:10.1371/journal.pone.0099209]
3. Nathisuwan S, Burgess DS, Lewis JS. Extended-Spectrum β-Lactamases: Epidemiology, Detection, and Treatment. Pharmacother. 2001; 21(8): 920-928. [DOI:10.1592/phco.21.11.920.34529]
4. Andersson MI, MacGowan AP. Development of the quinolones. J Antimicrob Chemother. 2003; 51(1): 1-11. [DOI:10.1093/jac/dkg212]
5. Drlica K, Zhao X. DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiol Mol Biol Rev. 1997; 61:377–92.
6. Hooper DC. Mechanisms of quinolone resistance. In: Hooper DC, Rubinstein E, eds. Quinolone antimicrobial agents. 3rd ed. Washington DC: American Society for Microbiology Press. 2003: 41-67.
7. Tran JH, Jacoby GA. Mechanism of plasmid-mediated quinolone resistance. Proc Natl Acad Sci USA. 2002; 99(8): 5638-42. [DOI:10.1073/pnas.082092899]
8. Robicsek A, Strahilevitz J, Jacoby GA, Macielag M, Abbanat D, Park CH, et al. Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase. Nat Med. 2006; 12:83–88. [DOI:10.1038/nm1347]
9. Martı´nez JL, Alonso A, Go´ mez-Go´ mez JM, et al. Quinolone resistance by mutations in chromosomal gyrase genes Just the tip of the iceberg? J Antimicrob Chemother. 1998; 42(6): 683-688. [DOI:10.1093/jac/42.6.683]
10. Nordmann P, Poirel L. Emergence of plasmid-mediated resistance to quinolones in Enterobacteriaceae. J Antimicrob Chemother. 2005; 56(3): 463-469. [DOI:10.1093/jac/dki245]
11. Wang M, Tran JH, Jacoby GA, Zhang Y, Wang F, Hooper DC. Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai, China. Antimicrob Agents Chemother. 2003; 47(7): 2242-2248. [DOI:10.1128/AAC.47.7.2242-2248.2003]
12. Wang MD, Sahm F, Jacoby JA, Hooper DC. Emerging plasmid-mediated quinolone resistance associated with the qnr gene in Klebsiella pneumoniae clinical isolates in the United States. Antimicrob Agents Chemother; 2004; 48(4): 1295-1299. [DOI:10.1128/AAC.48.4.1295-1299.2004]
13. Tran JH, Jacoby GA, Hooper DC. Interaction of the plasmid-encoded quinolone resistance protein Qnr with Escherichia coli DNA gyrase. Antimicrob Agents Chemother. 2005; 49(1): 118-25. [DOI:10.1128/AAC.49.1.118-125.2005]
14. Nordmann P, Poirel L. Emergence of plasmid-mediated resistance to quinolones in Enterobacteriaceae. J Antimicrob Chemother. 2005; 56(3): 463-469. [DOI:10.1093/jac/dki245]
15. Robicsek A, Jacoby GA, Hooper DC. The worldwide emergence of plasmid mediated quinolone resistance. Lancet Infect Dis. 2006; 6(10): 629-640. [DOI:10.1016/S1473-3099(06)70599-0]
16. CLSI. Performance Standards for Antimicrobial Susceptibility Testing. 21th ed. Wayne, PA: Clinical and Laboratory Standards Institute. 2011; 31: 84-87.
17. Tamang MD, Seol SY, Young Oh J, Kang HE, Lee JC, Lee YC, et al. Plasmid-mediated quinolone resistance determinants qnrA, qnrB, and qnrS among clinical isolates of Enterobacteriaceae in a Korean hospital. Antimicrob Agents and Chemother. 2008; 52(11): 4159-4162. [DOI:10.1128/AAC.01633-07]
18. Wang A, Yang Y, Lu Q, Wang Yi, Chen Y, Deng Li, et al. Presence of qnr gene in Escherichia coli and Klebsiella pneumoniae resistant to ciprofloxacin isolated from pediatric patients in China. BMC Infectious Diseases. 2008; 8(1): 68. DOI: 10.1186/1471-2334-8-68. [DOI:10.1186/1471-2334-8-68]
19. Saiful AAS, Anuar M, Mohd Yusof MY, Tay ST. Prevalence of plasmid-mediated qnr determinants and gyrase alteration in Klebsiella pneumoniae isolated from a university teaching hospital in Malaysia. Eur Rev Med and Pharmacol Sci. 2013; 17(13): 1744-47.
20. Al-Marzooq, F, Mohd Yusof MY, Tay ST. Molecular Analysis of Ciprofloxacin Resistance Mechanisms in Malaysian ESBL-Producing Klebsiella pneumoniae Isolates and Development of Mismatch Amplification Mutation Assays (MAMA) for Rapid Detection of gyrA and parC Mutations. BioMed research international. 2014; 2014: 601630. Doi: 10.1155/2014/601630. [DOI:10.1155/2014/601630]
21. Liao CH, Hush PR, Jacoby GA, Hooper DC. Risk factors and clinical characteristics of patients with qnr-positive Klebsiella pneumoniae bacteraemia. J Antimicrob Chemother 2013; 68 (12): 2907-2914. doi: 10.1093/jac/dkt295. [DOI:10.1093/jac/dkt295]
22. Soleimani Asl Y, Zibaei M, Firoozeh F. Detection of qnrA gene among quinolone-resistant Escherichia coli isolated from urinary tract infections in Khorram Abad during 2011-2012. Feyz. 2013; 13(5): 488-494.
23. Hong BK, Chi HP, Chung JK, Kim EC, Jacoby GA, Hooper DC. Prevalence of plasmid-mediated quinolone resistance determinants over a 9-year period. Antimicrob Agents Chemother 2009; 53(2): 639-645. doi: 10.1128/AAC.01051-08. [DOI:10.1128/AAC.01051-08]

Add your comments about this article : Your username or Email:

Send email to the article author

© 2007 All Rights Reserved | Medical Laboratory Journal

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.